| FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
1.132 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
1.132 |
Evidence |
|
| IL6 |
IL6, IFNB2: Interleukin-6 precursor |
IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
1.132 |
Evidence |
|
| CASP8 |
CASP8, MCH5: Caspase-8 precursor |
PEA15 |
PEA15: Astrocytic phosphoprotein PEA-15 |
1.132 |
Evidence |
|
| PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
1.132 |
Evidence |
|
| KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
1.132 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
DRD2 |
DRD2: D(2) dopamine receptor |
1.132 |
Evidence |
|
| EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
TNFSF13B |
TNFSF13B, BAFF, UNQ401/PRO738, BLYS, TALL1, TNFSF20, ZTNF4: Tumor necrosis facto |
1.132 |
Evidence |
|
| CASP1 |
CASP1, IL1BC, IL1BCE: Caspase-1 precursor |
CASP2 |
CASP2, ICH1, NEDD2: Caspase-2 precursor |
1.132 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
1.132 |
Evidence |
|
| MAPK10 |
MAPK10, JNK3, JNK3A, PRKM10: Mitogen-activated protein kinase 10 |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
1.132 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
1.132 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
1.132 |
Evidence |
|
| APOA1 |
APOA1: Apolipoprotein A-I precursor |
PLTP |
PLTP: Phospholipid transfer protein precursor |
1.132 |
Evidence |
|
| LIF |
LIF, HILDA: Leukemia inhibitory factor precursor |
IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
1.132 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
1.132 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
AZGP1 |
AZGP1, tcag7.638: Alpha-2-glycoprotein 1, zinc-binding |
1.132 |
Evidence |
|
| PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
1.132 |
Evidence |
|
| KITLG |
KITLG, MGF, SCF: Kit ligand precursor |
IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
1.132 |
Evidence |
|
| APS |
SH2B2, APS: SH2B adapter protein 2 |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
1.132 |
Evidence |
|
| NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
TNFSF13B |
TNFSF13B, BAFF, UNQ401/PRO738, BLYS, TALL1, TNFSF20, ZTNF4: Tumor necrosis facto |
1.132 |
Evidence |
|
| TRPM7 |
TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me |
TRPV4 |
TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb |
1.132 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
MAPK15 |
IPI00395861 |
1.132 |
Evidence |
|